ASSESSMENT OF THE RESULT OF BCR-ABL MUTATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS

dc.contributor.authorDemircioglu, S.
dc.contributor.authorBalasar, M.
dc.contributor.authorYildirim, M.
dc.date.accessioned2024-02-23T14:45:21Z
dc.date.available2024-02-23T14:45:21Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.endpageS40en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpageS40en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17375
dc.identifier.volume49en_US
dc.identifier.wosWOS:000391180600103en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofLeukemia Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleASSESSMENT OF THE RESULT OF BCR-ABL MUTATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTSen_US
dc.typeConference Objecten_US

Dosyalar